ReviewPharmacognosy reviews
Cadamba: A miraculous tree having enormous pharmacological implications.
Review in Pharmacognosy reviews. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- Metabolomic and transcriptomic analyses reveal the monoterpenoid indole alkaloid biosynthesis in Neolamarckia cadamba.Molecular biology reports · 2026Article
- Valorization ofRSC advances · 2026Article
- Comprehensive Secondary Metabolite Profiling and Antioxidant Activity of Aqueous and Ethanol Extracts ofMetabolites · 2024Article
- Evaluation of immunomodulatory (humoral as well as cell-mediated) and cytokines (TNF-α & IL-10) regulating potential of3 Biotech · 2024Article
- Countenance and implication of Β-sitosterol, Β-amyrin and epiafzelechin in nickel exposed Rat: in-silico and in-vivo approach.Scientific reports · 2023Article
- Unveiling the Cardioprotective Power: Liquid Chromatography-Mass Spectrometry (LC-MS)-AnalyzedPlants (Basel, Switzerland) · 2023Article
- Review
- Article
- Neolamarckia cadamba (Roxb.) Bosser (Rubiaceae) extracts: promising prospects for anticancer and antibacterial potential through in vitro and in silico studies.Medical oncology (Northwood, London, England) · 2023Article
- Green synthesis, characterization and biological activities of silver nanoparticles synthesized fromADMET & DMPK · 2023Article
- A complete sequence of mitochondrial genome of Neolamarckia cadamba and its use for systematic analysis.Scientific reports · 2021Article
- Cloning and characterization of the lignin biosynthesis genes NcCSE and NcHCT from Neolamarckia cadamba.AMB Express · 2019Article
- EVALUATION OF THE ANTI-INFLAMMATORY CAPACITY OF BETA-SITOSTEROL IN RODENT ASSAYS.African journal of traditional, complementary, and alternative medicines : AJTCAM · 2017Article
- Rapid Quantitative Analysis of Naringenin in the Fruit Bodies ofPharmacognosy magazineArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The Cadamba is one of the important medicinal plants belonging to the Rubiaceae family. It is crucially significant as it has the largest number of phytochemicals and secondary metabolites (viz., cadambagenic acid, cadamine, quinovic acid, β-sitosterol, cadambine, etc.) having pharmacological and biological properties. It can be used as an alternative to various synthetic chemical compounds in the prevention as well as the treatment of several incurable diseases. More than 100 years of research has been done to discover various phytochemicals and their implications. Very few of them, i.e. ≤2% have been commercialized due to the lack of a suitable model system as well as various associated controversial issues. The solubility of phytochemicals is another major concern: Further response that will be generated due to the solvent used is also unpredictable. Moreover, the Cadamba is one of the ornamental plants with religious significance. Here we have made an effort to summarize all the phytochemicals and their significance to render the interest that would help in their commercialization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.